Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wisconsin Health Press.
Press releases published on June 27, 2025
Sage Healthspan Launches AI-Powered, Privacy-First Wellness App to Bridge Critical Gaps in Preventative Healthcare
GlobeNewswire
·
June 27, 2025
Orange County, California, June 27, 2025 (GLOBE NEWSWIRE) -- Sage Healthspan, a California-based digital health company, announced its precision health app, now available for free on Apple’s App Store. Designed to address notable shortcomings in modern …
theranos Calls on President Trump to Pardon Elizabeth Holmes
GlobeNewswire
·
June 27, 2025
PALM BEACH, Fla., June 27, 2025 (GLOBE NEWSWIRE) -- In less than 24 hours after a meeting with the FDA, Ryan ElHosseiny, inventor and CEO of theranos, now calls on President Trump to pardon Elizabeth Holmes. ElHosseiny has been campaigning across America …
University of Bridgeport and Goodwin University Revolutionize Regenerative Medicine Training Program Forming Strategic Alliance with Globally Recognized TulsiHub Institute
GlobeNewswire
·
June 27, 2025
BRIDGEPORT, CT, June 27, 2025 (GLOBE NEWSWIRE) -- The two leading academic institutions have joined forces with TulsiHub Institute, the premier provider of advanced CE certified regenerative medicine certification programs, to transform medical education …
Information on the total number of voting rights and shares
GlobeNewswire
·
June 27, 2025
REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), June 27, 2025, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, …
Informations sur le nombre total de droits de vote et d'actions
GlobeNewswire
·
June 27, 2025
INFORMATION RÉGLEMENTÉE Informations sur le nombre total de droits de vote et d'actions Mont-Saint-Guibert (Belgique), le 27 juin 2025, 22:30h CET / 16:30h ET – Conformément à l'article 15 de la loi du 2 mai 2007 relative à la publicité des participations …
VitalHub Announces Results of Annual General Meeting of Shareholders
GlobeNewswire
·
June 27, 2025
TORONTO, June 27, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today the voting results from its annual general meeting of shareholders held virtually on June 27, 2025. All director nominees were …
Ahsan Ashraf Joins Jaylen Brown as Hapbee Investor, Executive and Board Member
GlobeNewswire
·
June 27, 2025
MONTREAL, June 27, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies Inc. (TSXV: HAPB), the digital wellness company behind the pioneering bio-streaming wearable platform, today announced the appointment of Ahsan Ashraf to its Board of Directors. Mr. Ashraf, a …
Pliant Therapeutics Provides Update on BEACON-IPF
GlobeNewswire
·
June 27, 2025
Bexotegrast development in IPF discontinued Clinical oncology program and early-stage programs continue Recent workforce and operational changes align with next steps SOUTH SAN FRANCISCO, Calif., June 27, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. …
Titan Pharmaceuticals Announces $600,000 Private Placement of Convertible Preferred Stock
GlobeNewswire
·
June 27, 2025
NEW YORK, June 27, 2025 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") announced today that, pursuant to a securities purchase agreement (the “Purchase Agreement”) with Blue Harbour Asset Management L.L.C-FZ (“ …
Xenon Joins the Russell 3000® and Russell 2000® Indexes
GlobeNewswire
·
June 27, 2025
VANCOUVER, British Columbia and BOSTON, June 27, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for …
RetinalGenix Technologies Contracts with LabCorp to Support DNA/GPS Platform for Advanced Genetic and Retinal Health Screening
GlobeNewswire
·
June 27, 2025
APOLLO BEACH, Fla., June 27, 2025 (GLOBE NEWSWIRE) -- RetinalGenix Technologies Inc. OTCQB:RTGN (“RetinalGenix” or the “Company”), a pioneering developmental-stage company focused on ophthalmic screening, monitoring, pharmacogenetic mapping, and repurposed …
QuietLab Anti-Snoring Mouthpiece Helps Couples Sleep Better and Improve Sleep Health
GlobeNewswire
·
June 27, 2025
New York, USA, June 27, 2025 (GLOBE NEWSWIRE) -- Snoring continues to affect millions of individuals and their partners, often disrupting sleep and straining relationships. Now, QuietLab is addressing this growing issue with its new anti-snoring mouthpiece …
Theranos Makes a Big Bang at the FDA
GlobeNewswire
·
June 27, 2025
PALM BEACH, Fla., June 27, 2025 (GLOBE NEWSWIRE) -- Today marks a significant milestone for theranos and its diagnostic technology. The theranos system performs automated sample processing and analysis to produce clinical test results. The U.S. Food and …
INmune Bio, Inc. Announces Approximately $19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GlobeNewswire
·
June 27, 2025
Boca Raton, Florida, June 27, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company, today announced that it has entered into securities purchase agreements with two healthcare focused …
Biosimilars Market on the Rise: Expected 19.4% CAGR Over Next Five Years
GlobeNewswire
·
June 27, 2025
Boston, June 27, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Biosimilars: Global Markets” is expected to grow from $28.5 billion in 2024 to $69.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 19.4% …
New Data for Nusinersen Underscore Biogen’s Commitment to Advancing Clinical Research to Improve Outcomes in SMA
GlobeNewswire
·
June 27, 2025
New analyses from DEVOTE Part C further characterize the improvements in motor function in participants with SMA who transitioned to the investigational higher dose regimen of nusinersen from 12 mg SPINRAZA® (nusinersen) Final results from the landmark …
Safety Shot Completes Acquisition of Yerbae Brands Corp.
GlobeNewswire
·
June 27, 2025
SCOTTSDALE, Ariz., June 27, 2025 (GLOBE NEWSWIRE) -- Yerbaé Brands Corp. (TSX-V: YERB.U; OTCQX: YERBF) (“Yerbaé”), a plant-based energy beverage company, and Safety Shot, Inc. (Nasdaq: SHOT) (“SHOT”, “Safety Shot”, or the “Company”), a wellness and dietary …
Channel Therapeutics Announces Reverse Common Stock Split in Conjunction with the Close of the Merger with Pelthos Therapeutics and Concurrent $50.1 Million Private Placement
GlobeNewswire
·
June 27, 2025
FREEHOLD, N.J., June 27, 2025 (GLOBE NEWSWIRE) -- Channel Therapeutics Corporation, (“Channel” or the “Company”), (NYSE American: CHRO), an emerging leader in the development of non-opioid pain treatment therapeutics, today announced a 10-for-one reverse …
ALPHA PRO TECH, LTD. ANNOUNCES $2 MILLION EXPANSION OF SHARE REPURCHASE PROGRAM
GlobeNewswire
·
June 27, 2025
NOGALES, Ariz., June 27, 2025 (GLOBE NEWSWIRE) -- – Alpha Pro Tech, Ltd. (NYSE American: APT), a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, today …
Clearmind Medicine Expands Global Clinical Trial Targeting Multibillion-Dollar Alcohol Use Disorder Market
GlobeNewswire
·
June 27, 2025
Vancouver, Canada, June 27, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …